tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Technical Analysis

Compare
417 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is 0.75, suggesting ARS Pharmaceuticals is a Sell.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 17.09, while ARS Pharmaceuticals’s (SPRY) share price is $18.35, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 15.85, while ARS Pharmaceuticals’s (SPRY) share price is $18.35, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Jul 18, 2025, 07:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.21
17.39
17.63
17.81
18.05
18.23
18.47
Fibonacci
17.39
17.55
17.65
17.81
17.97
18.07
18.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Jul 18, 2025, 07:35 PM
Period
Simple
Exponential
MA5
17.87Buy
17.92Buy
MA10
17.58Buy
17.65Buy
MA20
17.24Buy
17.09Buy
MA50
15.39Buy
15.85Buy
MA100
14.05Buy
14.77Buy
MA200
13.75Buy
14.01Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 17.65, while ARS Pharmaceuticals’s (SPRY) share price is $18.35, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 14.77, while ARS Pharmaceuticals’s (SPRY) share price is $18.35, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $18.35 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 15.39, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $18.35 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 14.05, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $18.35 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 13.75, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Jul 18, 2025, 07:35 PM
Name
Value
Implied Action
RSI (14)
63.98
Neutral
STOCH (9,6)
83.99
Sell
STOCHRSI (14)
69.10
Neutral
MACD (12,26)
0.75
Sell
ADX (14)
30.43
Neutral
Williams %R
-17.46
Sell
CCI (14)
102.93
Sell
ATR (14)
0.87
-
Ultimate Oscillator
64.73
Neutral
ROC
1.49
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 63.98, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 30.43, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 102.93, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 1.49, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 63.98, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is 0.75, which suggests SPRY is a Sell.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 17.87, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 17.24, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 15.39, which suggests SPRY is a Buy.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 13.75, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -17.46, which suggests SPRY is a Sell.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 102.93, which suggests SPRY is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis